Signaturefd, LLC Charles River Laboratories International, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,016 shares of CRL stock, worth $198,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,016

Previous 1,035 1.84%

Holding current value

$198,902

Previous $213,000 6.1%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$187.96 - $245.29 $3,571 - $4,660	-19 Reduced 1.84%	1,016 $200,000
Q2 2024 Jul 29, 2024	SELL	$206.39 - $268.73 $2,063 - $2,687	-10 Reduced 0.96%	1,035 $213,000
Q1 2024 May 03, 2024	BUY	$203.52 - $273.43 $3,052 - $4,101	15 Added 1.46%	1,045 $283,000
Q4 2023 Jan 31, 2024	SELL	$164.52 - $238.84 $56,430 - $81,922	-343 Reduced 24.98%	1,030 $243,000
Q3 2023 Nov 03, 2023	BUY	$194.44 - $217.61 $77,387 - $86,608	398 Added 40.82%	1,373 $269,000
Q2 2023 Aug 01, 2023	SELL	$183.71 - $210.25 $53,827 - $61,603	-293 Reduced 23.11%	975 $204,000
Q1 2023 Apr 28, 2023	SELL	$191.89 - $259.92 $21,107 - $28,591	-110 Reduced 7.98%	1,268 $255,000
Q4 2022 Jan 27, 2023	BUY	$197.11 - $250.07 $42,969 - $54,515	218 Added 18.79%	1,378 $300,000
Q3 2022 Nov 08, 2022	SELL	$182.44 - $250.54 $16,966 - $23,300	-93 Reduced 7.42%	1,160 $228,000
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $1,837 - $2,721	9 Added 0.72%	1,253 $268,000
Q1 2022 May 02, 2022	BUY	$255.51 - $362.11 $22,484 - $31,865	88 Added 7.61%	1,244 $353,000
Q4 2021 Jan 25, 2022	SELL	$351.38 - $448.68 $80,466 - $102,747	-229 Reduced 16.53%	1,156 $436,000
Q3 2021 Oct 28, 2021	BUY	$372.64 - $458.3 $85,707 - $105,409	230 Added 19.91%	1,385 $572,000
Q2 2021 Jul 26, 2021	SELL	$294.17 - $371.65 $1,176 - $1,486	-4 Reduced 0.35%	1,155 $427,000
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $24,467 - $29,349	98 Added 9.24%	1,159 $336,000
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $222,444 - $253,125	-1,002 Reduced 48.57%	1,061 $265,000
Q3 2020 Nov 03, 2020	BUY	$175.56 - $226.45 $14,747 - $19,021	84 Added 4.24%	2,063 $467,000
Q2 2020 Jul 30, 2020	BUY	$118.84 - $189.72 $117,057 - $186,874	985 Added 99.09%	1,979 $345,000
Q1 2020 Apr 23, 2020	BUY	$98.9 - $178.34 $2,076 - $3,745	21 Added 2.16%	994 $125,000
Q4 2019 Feb 05, 2020	BUY	$126.05 - $152.76 $3,025 - $3,666	24 Added 2.53%	973 $149,000
Q3 2019 Oct 16, 2019	SELL	$125.07 - $143.67 $625 - $718	-5 Reduced 0.52%	949 $126,000
Q2 2019 Jul 31, 2019	SELL	$123.4 - $148.55 $8,761 - $10,547	-71 Reduced 6.93%	954 $135,000
Q1 2019 May 09, 2019	SELL	$104.82 - $146.73 $2,934 - $4,108	-28 Reduced 2.66%	1,025 $149,000
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $7,356 - $9,606	70 Added 7.12%	1,053 $119,000
Q1 2018 May 08, 2018	BUY	$98.19 - $115.2 $96,520 - $113,241	983 New	983 $105,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account